| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |